Share This

  • The new injectable solution based on hyaluronic acid – with a specific indication for the restoration of adipose tissue,1  which helps fight facial aging – is now available
  • Thanks to the high concentration of Ultrapure hyaluronic acid and its regenerative effect, Profhilo® Structura helps restore firmness to the face, directly acting on the adipose tissue1,2

Contains 1 injectable treatment PROFHILO® STRUCTURA, 1 TSK 22Gx50mm cannula, 1 TSK 21Gx25mm pilot needle, 1 TSK 25Gx38mm cannula, 1 TSK 23Gx19mm pilot needle.

PROFHILO® STRUCTURA 2ml pre-filled syringe (4.5% – 45mg L-HA + 45mg H-HA (Total 90mg)/2ml).

Injectable treatment with the specific intended use for the restoration of adipose tissue for facial treatment.3

PROFILE® STRUCTURA is characterised by Stable Hybrid Cooperative Complexes (HCC) of high- (1100-1400 kDa) and low- (80-100 kDa) molecular-weight Ultrapure Hyaluronic Acid at high concentration, produced through a unique and innovative thermal process patented by IBSA: NAHYCO Technology®.1,4

PROFHILO® STRUCTURA allows to reshape the structure of the face through a lipolifting action that improves the atrophy of the adipose compartments due to aging.5

--------------------------------------------------------------------------

  1. Profhilo® Structura, Instructions for Use
  2. Sparavigna A, Grimolizzi F, Cigni C, Lualdi R, Bellia G. Efficacy and tolerability of Profhilo® Structura intended to restore lateral cheek fat compartment: An observational pilot study. Health Sci Rep. 2024 Jan 21;7(1):e1743
  3. Profhilo® Structure, Instructions for Use
  4. Humzah D, Molina B, Salti G, Cigni C, Bellia G, Grimolizzi F. Intradermal Injection of Hybrid Complexes of High- and Low-Molecular-Weight Hyaluronan: Where Do We Stand and Where Are We Headed in Regenerative Medicine? Int J Mol Sci. 2024 Mar 12;25(6):3216.
  5. Sparavigna A, Grimolizzi F, Cigni C, Lualdi R, Bellia G. Efficacy and tolerability of Profhilo® Structura intended to restore lateral cheek fat compartment: An observational pilot study. Health Sci Rep. 2024 Jan 21;7(1):e1743